Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124721623 | 12472162 | 3 | F | 20130916 | 20160921 | 20160616 | 20160926 | PER | US-PFIZER INC-2016293675 | PFIZER | 62.00 | YR | M | Y | 56.00000 | KG | 20160926 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124721623 | 12472162 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 MG, 3X/DAY | Y | L91585 | 21110 | 1 | MG | TID | |||||
| 124721623 | 12472162 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 MG, 3X/DAY | Y | M85178 | 21110 | 1 | MG | TID | |||||
| 124721623 | 12472162 | 3 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 2 MG, 1X/DAY | Y | M85173 | 21110 | 2 | MG | QD | |||||
| 124721623 | 12472162 | 4 | C | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | ||||||
| 124721623 | 12472162 | 5 | C | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | UNK | 0 | TABLET | ||||||||||
| 124721623 | 12472162 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
| 124721623 | 12472162 | 7 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 124721623 | 12472162 | 8 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | QD | ||||||||
| 124721623 | 12472162 | 9 | C | CALCIUM-D3 | 2 | 1 DF, 2X/DAY | 0 | 1 | DF | BID | |||||||||
| 124721623 | 12472162 | 10 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | 1 PUFF, 4X/DAY | 0 | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124721623 | 12472162 | 1 | Prophylaxis against transplant rejection |
| 124721623 | 12472162 | 2 | Liver transplant |
| 124721623 | 12472162 | 4 | Antiviral prophylaxis |
| 124721623 | 12472162 | 6 | Transplant rejection |
| 124721623 | 12472162 | 8 | Osteoporosis |
| 124721623 | 12472162 | 9 | Osteoporosis |
| 124721623 | 12472162 | 10 | Chronic obstructive pulmonary disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124721623 | 12472162 | Feeling abnormal | |
| 124721623 | 12472162 | Hot flush | |
| 124721623 | 12472162 | Liver function test abnormal | |
| 124721623 | 12472162 | Product use issue | |
| 124721623 | 12472162 | Upper respiratory tract infection | |
| 124721623 | 12472162 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124721623 | 12472162 | 1 | 201309 | 0 | ||
| 124721623 | 12472162 | 3 | 20130916 | 0 | ||
| 124721623 | 12472162 | 4 | 20130911 | 0 | ||
| 124721623 | 12472162 | 5 | 20130911 | 0 | ||
| 124721623 | 12472162 | 6 | 20130911 | 0 | ||
| 124721623 | 12472162 | 7 | 20130911 | 0 | ||
| 124721623 | 12472162 | 10 | 200904 | 0 |